HCM
LUMO

Highbridge Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Highbridge Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,517
Closed -$872K – 2028
2017
Q3 		$872K Buy
+9,517
New +$730K 0.01% 652

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Highbridge Capital Management's LUMO Position: Q4 2017 in Review

Highbridge Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2017, closing a stake of 9,517 shares — an estimated $872K sold.

Highbridge Capital Management first reported a position in LUMO in Q3 2017 and held it in 1 quarter. The position peaked at $872K in Q3 2017. 130 funds tracked by Wall St. Rank hold LUMO as of Q4 2017.

  • Highbridge Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 9,517 Lumos Pharma, Inc. Common Stock shares in Q4 2017, an estimated $872K.
  • Highbridge Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Highbridge Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $872K in Q3 2017.
  • 130 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2017.

Based on Highbridge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.